Oncological outcomes after a pathological complete response following total neoadjuvant therapy or chemoradiotherapy for high-risk locally advanced rectal cancer in the RAPIDO trial

医学 危险系数 新辅助治疗 结直肠癌 癌胚抗原 内科学 优势比 放射治疗 放化疗 化疗 全直肠系膜切除术 胃肠病学 肿瘤科 置信区间 直肠 外科 癌症 乳腺癌
作者
W.H. Zwart,Sofieke J. D. Temmink,Geke A.P. Hospers,Corrie A.M. Marijnen,Hein Putter,Irıs D. Nagtegaal,Lennart Blomqvist,Elma Meershoek‐Klein Kranenbarg,Annet G.H. Roodvoets,Anna Martling,Cornelis J.�H. van de Velde,Bengt L. G. Glimelius,Koen C.M.J. Peeters,Boudewijn van Etten,Per Johan Nilsson
出处
期刊:European Journal of Cancer [Elsevier BV]
卷期号:204: 114044-114044 被引量:49
标识
DOI:10.1016/j.ejca.2024.114044
摘要

Background A pathological complete response (pCR) following chemoradiation (CRT) or short-course radiotherapy (scRT) leads to a favourable prognosis in patients with rectal cancer. Total neo-adjuvant therapy (TNT) doubles the pCR rate, but it is unknown whether oncological outcomes remain favourable and whether the same characteristics are associated with pCR as after CRT. Methods Comparison between patients with pCR in the RAPIDO trial in the experimental [EXP] (scRT, chemotherapy, surgery, as TNT) and standard-of-care treatment [STD] ( CRT , surgery, postoperative chemotherapy depending on hospital policy) groups. Primary and secondary outcomes were time-to-recurrence (TTR), overall survival (OS) and association between patient, tumour, and treatment characteristics and pCR. Results Among patients with a resection within six months after preoperative treatment, 120/423 (28%) [EXP] and 57/398 (14%) [STD] achieved a pCR. Following pCR, 5-year cumulative TTR and OS rates in the EXP and STD arms were 8% vs. 7% (hazard ratio 1.04, 95%CI 0.32-3.38) and 94% vs. 93% (hazard ratio 1.41, 95%CI 0.51-3.92), respectively. Besides the EXP treatment (odds ratio 2.70, 95%CI 1.83-3.97), pre-treatment carcinoembryonic antigen (CEA) <5, pre-treatment tumour size <40 mm and cT2 were associated with pCR. Distance from the anal verge was the only characteristic with a statistically significant difference in association with pCR between the EXP and STD treatment (P interaction =0.042). pCR rates did not increase with prolonged treatment time. Conclusions The doubled pCR rate of TNT compared to CRT results in similar oncological outcomes. Characteristics associated with pCR are the EXP treatment, normal CEA, and small tumour size.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
PDIF-CN2完成签到,获得积分10
1秒前
千陽发布了新的文献求助10
1秒前
pipizhu发布了新的文献求助10
1秒前
hungry完成签到,获得积分10
1秒前
3秒前
思源的应助被研友_ndvmV8采纳,获得20
3秒前
000完成签到 ,获得积分10
3秒前
我是老大的应助被eee采纳,获得10
4秒前
Levon发布了新的文献求助10
4秒前
CK组发布了新的文献求助10
4秒前
4秒前
哈哈哈发布了新的文献求助10
4秒前
无奈的煎饼完成签到 ,获得积分10
4秒前
null的应助被科研通管家采纳,获得10
4秒前
4秒前
今后的应助被科研通管家采纳,获得10
4秒前
4秒前
null的应助被科研通管家采纳,获得10
4秒前
奋斗瑶发布了新的文献求助10
4秒前
咯咯哒给咯咯哒的求助进行了留言
4秒前
5秒前
Hello的应助被科研通管家采纳,获得10
5秒前
5秒前
null的应助被科研通管家采纳,获得10
5秒前
5秒前
YOU完成签到,获得积分20
5秒前
星辰大海的应助被科研通管家采纳,获得10
5秒前
英姑的应助被hh采纳,获得10
5秒前
初雪的应助被科研通管家采纳,获得10
5秒前
NexusExplorer的应助被baoziya采纳,获得10
5秒前
5秒前
5秒前
祝新竹完成签到,获得积分10
6秒前
小太阳在营业的应助被OK采纳,获得250
6秒前
完美世界的应助被风趣的扬青采纳,获得10
7秒前
传奇3的应助被负责的代亦采纳,获得10
7秒前
清秀芝麻完成签到,获得积分10
7秒前
7秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8161319
求助须知:如何正确求助?哪些是违规求助? 9556017
关于积分的说明 21731933
捐赠科研通 7751355
什么是DOI,文献DOI怎么找? 3427537
关于科研通互助平台的介绍 2552583
邀请新用户注册赠送积分活动 2471987